These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38616606)

  • 21. Patient practices regarding topical drugs and a 'nudge' to prevent topical steroid abuse.
    Barve A; Petkar S; Farande P; Patel J; Raval A
    Clin Exp Dermatol; 2021 Apr; 46(3):575-577. PubMed ID: 33131125
    [No Abstract]   [Full Text] [Related]  

  • 22. A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India.
    Pathania S; Rudramurthy SM; Narang T; Saikia UN; Dogra S
    Indian J Dermatol Venereol Leprol; 2018; 84(6):678-684. PubMed ID: 30058568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical steroid-induced tinea pseudoimbricata: a striking form of tinea incognito.
    Verma S; Hay RJ
    Int J Dermatol; 2015; 54(5):e192-3. PubMed ID: 25601089
    [No Abstract]   [Full Text] [Related]  

  • 24. Tinea of vellus hair: a diagnostic and therapeutic challenge.
    Eksomtramage T; Aiempanakit K
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29437818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A tinea incognito case caused by Trichophyton rubrum with clinical and mycological cure and review of the literature].
    Ilkit M; Karakaş M; Yüksel T
    Mikrobiyol Bul; 2010 Jan; 44(1):149-53. PubMed ID: 20455412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interest and justification of general corticosteroid therapy in suppurative tinea (kerion) (author's transl)].
    Barrière H; Litoux P
    Ann Dermatol Venereol; 1977 Apr; 104(4):294-7. PubMed ID: 889232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of tinea incognito mimicking subcorneal pustular dermatosis.
    Kalkan G; Demirseren DD; Güney CA; Aktaş A
    Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical antifungal drugs in the treatment of tinea pedis, tinea cruris, and tinea corporis.
    Smith EB
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):S24-S28. PubMed ID: 8496408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal therapeutic failures in India: an important issue being overlooked.
    Sonthalia S; Agrawal M; Goldust M; Das S; Bhattacharya SN
    Lancet Infect Dis; 2018 Nov; 18(11):1181-1182. PubMed ID: 30507401
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tinea incognito. Masking of cutaneous fungal infections by local corticosteroid therapy].
    Frentz G
    Ugeskr Laeger; 1976 Oct; 138(41):2499-501. PubMed ID: 973255
    [No Abstract]   [Full Text] [Related]  

  • 31. Intralesional steroids in dermatophytosis: Quackery in India takes new route.
    Srivastava A; Agrawal S
    Indian J Dermatol Venereol Leprol; 2019; 85(5):568. PubMed ID: 30504531
    [No Abstract]   [Full Text] [Related]  

  • 32. [Oral Antifungal Drugs in the Treatment of Dermatomycosis].
    Tsunemi Y
    Med Mycol J; 2016; 57(2):J71-5. PubMed ID: 27251319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncovering tinea incognito. Topical corticosteroids can mask typical features of ringworm.
    Oklota CA; Brodell RT
    Postgrad Med; 2004 Jul; 116(1):65-6. PubMed ID: 15274290
    [No Abstract]   [Full Text] [Related]  

  • 34. New Antifungal Agents and New Formulations Against Dermatophytes.
    Gupta AK; Foley KA; Versteeg SG
    Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tinea corporis by Nannizia gypsea: delayed diagnosis due to unusual presentation.
    Soares JJ; Sousa NA; Azulay-Abulafia L; Costa RO
    An Bras Dermatol; 2021; 96(1):91-93. PubMed ID: 33281009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Follicular trichophytosis of the face with concurrent mycosis of the finger nails].
    Hauck H; Diezemann V
    Mykosen; 1971 May; 14(5):233-6. PubMed ID: 4252600
    [No Abstract]   [Full Text] [Related]  

  • 37. A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India.
    Balasubramanian A; Akbar Ali NA; Pugazhenthi A; Gopalan K; Tamil Selvan S; Ramalingam K
    Mycoses; 2024 Feb; 67(2):e13707. PubMed ID: 38366126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review.
    van Zuuren EJ; Fedorowicz Z; El-Gohary M
    Br J Dermatol; 2015 Mar; 172(3):616-41. PubMed ID: 25294700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tinea incognito.
    Arenas R; Moreno-Coutiño G; Vera L; Welsh O
    Clin Dermatol; 2010 Mar; 28(2):137-9. PubMed ID: 20347654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of topical griseofulvin in treatment of tinea corporis.
    Kassem MA; Esmat S; Bendas ER; El-Komy MH
    Mycoses; 2006 May; 49(3):232-5. PubMed ID: 16681816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.